2000 Curtis Rd. Adrian, MI 49221

Medical Dermatology: (517) 264-5603

Cosmetic Dermatology: (517) 759-3191

2000 Curtis Rd. Adrian, MI 49221

Cosmetic Dermatology: (517) 759-3191

Medical & General Dermatology: (517) 264-5603

2000 Curtis Rd. Adrian, MI 49221

Cosmetic Dermatology: (517) 759-3191

Medical & General Dermatology: (517) 264-5603

2000 Curtis Rd. Adrian, MI 49221

Cosmetic Dermatology: (517) 759-3191

Medical & General Dermatology: (517) 264-5603


Image-Guided Superficial Radiotherapy (IG-SRT)

Image-Guided Superficial Radiotherapy (IG-SRT)

Image-Guided Superficial Radiotherapy (IG-SRT)

Image-Guided Superficial Radiotherapy (IG-SRT)

Image-Guided Superficial Radiotherapy (IG-SRT) is chosen by informed patients who may not be ideal candidates for Mohs surgery or are seeking a non-invasive option for treating basal cell and squamous cell carcinoma skin cancers on any area of the body.

About IG-SRT


IG-SRT is performed using the SRT 100-Vision. This advanced technology cures cancer by using low levels of x-ray radiation safely and effectively, right here in the office. Ultrasound imaging is used to determine the depth and width of the lesion in order to calculate the dose needed. Once the dose is determined, the precise quality and quantity of radiation is transmitted through the machine to penetrate the lesion. The levels of radiation used for these treatments are similar to those used during dental x-rays. 100% of the dose is given directly to the cancer cells, whiling sparing the normal healthy tissue.

Based on a clinical study of 2,781 lesions, IG-SRT was shown to be more than 99% effective in curing both squamous cell and basal cell carcinoma. This compares favorably to the results for Mohs Surgery as reported by the American Academy of Dermatology. It’s important to note the results for IG-SRT are not applicable to non-image guided radiotherapy procedures and IG-SRT is the only radiotherapy-based procedure proven to provide superior outcomes.
Treatment Option Squamous Cell Carcinoma Basal Cell Carcinoma
IG-SRT with SkinCure Oncology Protocol1 99.3% 99.5%
Mohs Surgery2 96.0% 98.0%
SRT without image guidance and without SkinCure 75.0% 89.0%
Oncology Protocol2
Image-Guided Superficial Radiotherapy at Dr. Desjarlais' Office in Adrian, MI
Image-Guided Superficial Radiotherapy at Dr. Desjarlais' Office in Adrian, MI
Image-Guided Superficial Radiotherapy at Dr. Desjarlais' Office in Adrian, MI
Image-Guided Superficial Radiotherapy at Dr. Desjarlais' Office in Adrian, MI

Why We Recommend IG-SRT

Why We Recommend 
IG-SRT


Skin cancer is the most prevalent of all cancers, affecting more than 1 million Americans every year. Here at Desjarlais Dermatology we discuss all options for treatment. However, here are the reasons we feel confident in utilizing IG-SRT:
  1. Reduces Risks to the Patient. According to the Mayo Clinic, patients undergoing Mohs surgery face a number of risks, including scar formation at the site of tumor removal; larger than expected wound creation upon removal of the skin cancer; poor wound healing; excessive bleeding; infection; loss of nerve function; regrowth of the tumor; and cosmetic or functional deformities. IG-SRT is a radiotherapy-based treatment and no surgical intervention is required. While Mohs surgery is a relatively safe procedure for patients without comorbidities, risks do increase for patients with diabetes, high or low blood pressure, peripheral artery disease, lymphedema, and other conditions. In addition, patients taking blood thinners and other medications that affects the blood’s ability to coagulate may be at increased risk.
  2. Offers Superior Cosmetic Results. IG-SRT is an especially attractive treatment option for patients concerned with undergoing a surgical procedure or worried about the potential for disfigurement.
  3. Offers More Consistent Results Than Competing Treatment Options. When performing Mohs surgery, the skill level of the surgeon may have a significant impact on the results, most especially as it relates to the cosmetic outcome. However, with SkinCure Oncology’s IG-SRT treatment, the outcome is not dependent on the skills level or experience of a surgeon. Instead, the practical model is built on cancer center protocols and staffing guidelines that include radiation safety officers, radiation facility protocols, trained radiation therapist technologists, and medical physicists.

What to Expect During 
IG-SRT Treatment

What to Expect During IG-SRT Treatment


We understand non-melanoma skin cancer patients who chose IG-SRT Squamous cell or Basal cell cancer treatments will have questions before they begin the treatment process. You deserve to feel confident and educated before starting your IG-SRT treatment. 

When you visit our office for IG-SRT treatment, you’ll be met with care and compassion from knowledgeable Dermatologists, Radiation Therapists, and support staff. Think of them as your dedicated care team, here to guide you through every step of your Squamous cell or Basal cell cancer treatment process. Here’s a step-by-step overview of what to expect:
  1. Your review and signing of informed consent to discuss treatment expectations.
  2. A simulation where photos, ultrasound images, and treatment parameters are entered into a computer for documentation and reproducibility. (No treatment on this day.)
  3. Treatments are typically 3 or 4 times weekly for a total of approximately 21 total treatments. The exact number will be determined at your first appointment. 
  4. You will generally be treated by the same Radiation Therapist each time you come in, but all Radiation Therapists are trained to treat you.
  5. Your Radiation Therapist will evaluate your skin reaction daily. The Physician will see you every 5 treatments. 
  6. Your care team will recommend medication as needed for skin reactions, change your treatment if necessary, or place you on a break for a short period if the skin needs some rest from the treatment.
  7. The healing process will continue for weeks after your last treatment. You will follow up with the Radiation Therapist and Physician to ensure that the treatment area has fully healed. 

Schedule An Appointment


If you’re seeking a non-invasive option for treating basal cell and squamous cell carcinoma skin cancers contact our office to schedule a meeting with Dr. Desjarlais and his team.

Book Appointment
Share by: